The safety lancets market was valued at approximately US$ 2.1 billion in 2023 and is projected to expand to US$ 6.32 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.54% from 2024 to 2034. Key drivers of this growth include the rising demand for point-of-care diagnostics, the need to prevent needlestick injuries, and ongoing technological advancements.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5277
Safety lancets are small, sharp devices used to puncture the skin for blood sampling. Unlike standard lancets, which pose a risk of needlestick injuries, safety lancets feature retractable needles that minimize accidental pricks and reduce the risk of infection. These devices are designed to deliver precise, predetermined puncture depths for effective blood sample collection. Safety lancets are primarily utilized for blood glucose monitoring and various tests, including lipid profiles, HbA1C, and blood typing.
The growing prevalence of chronic diseases such as diabetes and high cholesterol is driving demand for safety needles. Additionally, the rise in needlestick injuries associated with conventional lancets further encourages the shift towards safety lancets. Technological innovations and advancements in the design of safety lancets are also contributing to market expansion.
In April 2024, HTL-Strefa announced expanded FDA approval for its Droplet Micron 34G x 3.5 mm pen needle, allowing it to transition from prescription-only to over-the-counter status. This needle will not only be used for insulin delivery but also for the subcutaneous injection of GLP-1 analogs.
B.Braun reported sales of around 8,755 million EUR in 2023, marking a 3% increase from the previous year, with a gross profit of 3,322.4 million EUR. The company invested 484.6 million EUR in research and development during the same period.
The emergence of blood self-sampling devices, or lancing devices, is significantly boosting the demand for safety lancets. These devices automate blood sample collection, offering a standardized and safe method for obtaining blood, which is especially beneficial for children, the elderly, and individuals who fear needles. The introduction of self-sampling devices enhances patient adherence to testing protocols and integrates seamlessly with current total lab automation systems. They are designed to be affordable, sustainable, and high-quality, with the capability to collect blood from the upper arm or via finger pricks. These advancements are particularly valuable for patients in remote areas who require laboratory testing.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/safety-lancets-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5277
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Visit Dental Specifics: https://www.towardsdental.com
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global microfluidics market, valued at approximately US$ 31.80 billion in 2023, is projected to experience remarkable growth, reaching an… Read More
In the past decade, clinical microbiology laboratories have undergone a significant transformation, driven by advancements in molecular biology techniques and… Read More
The healthcare landscape continues to evolve with groundbreaking advancements and investments aimed at improving patient care, enhancing access to treatments,… Read More
The global cancer vaccines market, valued at US$ 10.21 billion in 2023, is set to experience remarkable growth, with a… Read More
Human error remains a significant challenge in the healthcare sector, contributing to avoidable waste, rising costs, and potential risks to… Read More
Telemedicine is revolutionizing the healthcare industry, offering numerous benefits that are making healthcare more accessible, efficient, and affordable. By leveraging… Read More